Abstract
FRAX is developed based on the use of clinical risk factor with or without bone mineral density. It would be expected in diagnosis of osteoporosis that FRAX(R) would be used in a group examination, in medical institution which does not have DEXA, and at home. However, results of FRAX are expressed as percentage indication which is not familiar to Japanese. We did questionnaire survey to the osteoporosis patient about the results of FRAX. As a result, fracture risk is thought of seriously by the initial diagnosis patient, the younger patient, and the patient with interest in osteoporosis. It is necessary to explain fracture risk of FRAX on the basis of patient background in clinical use.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
